Formulate Labs, Inc. — Form D
Formulate Labs, Inc. of Fenton, MO, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-07. The offering totals $2.5M, of which $1.4M was reported sold. Industry: Other.
Offering
- Filed: 2020-10-07
- Form: D
- Accession: 0001827318-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $1.4M
- Remaining: $1.1M
- Investors: 7
- Date of first sale: 2020-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-377298
Issuer
- Name: Formulate Labs, Inc.
- CIK: 0001827318
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1645 Headland Dr., Fenton, MO, 63026
- Phone: 312-283-4854
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jason Calacanis | Director | Los Angeles, CA |
| Osmaan Shah | Director | Fenton, MO |
| Osmaan Shah | Executive Officer | Fenton, MO |
| Michael Savino | Director | Fenton, MO |
Other filings by this issuer (1)
More